Effect of a Single Bolus of Erythropoietin on Renoprotection in Patients Undergoing Thoracic Aortic Surgery With Moderate Hypothermic Circulatory Arrest

Annals of Thoracic Surgery

Volumn 101, Issue 2, 2016, Pages 690-696

  Kim, Ji Eun ^a   Song, Suk Won ^a   Kim, Jong Yeop ^b   Lee, Hyun Joo ^a   Chung, Kum Hee ^c   Shim, Yon Hee ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN; HYPERTENSIVE FACTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE; ERYTHROPOIETIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONSTIPATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEEP HYPOTHERMIC CIRCULATORY ARREST; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TREATMENT FAILURE; EDEMA; FEMALE; FEVER; HEART ARRHYTHMIA; HEART INDEX; HEART INFARCTION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; RISK INJURY FAILURE LOSS OF FUNCTION AND END STAGE RENAL DISEASE CRITERIA; SIDE EFFECT; SINGLE DRUG DOSE; SURGICAL PATIENT; TACHYCARDIA; THORACIC AORTA SURGERY; THROMBOEMBOLISM; UROGENITAL TRACT DISEASE ASSESSMENT; URTICARIA; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; MIDDLE AGED; PROCEDURES; VERY ELDERLY;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; DOUBLE-BLIND METHOD; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84973452262     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2015.08.007     Document Type: Article

References (26)

1. 1 Roh, G.U., Lee, J.W., Nam, S.B., Lee, J., Choi, J.R., Shim, Y.H., Incidence and risk factors of acute kidney injury after thoracic aortic surgery for acute dissection. Ann Thorac Surg 94 (2012), 766–771.
2. 2 Kheterpal, S., Tremper, K.K., Heung, M., et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 110 (2009), 505–515.
3. 3 Bellomo, R., Kellum, J.A., Ronco, C., Acute kidney injury. Lancet 380 (2012), 756–766.
4. 4 Nangaku, M., Tissue protection by erythropoietin: new findings in a moving field. Kidney Int 84 (2013), 427–429.
5. 5 Solling, C., Christensen, A.T., Krag, S., et al. Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury. Acta Anaesthesiol Scand 55 (2011), 185–195.
6. 6 Gong, H., Wang, W., Kwon, T.H., et al. EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 66 (2004), 683–695.
7. 7 Johnson, D.W., Pat, B., Vesey, D.A., Guan, Z., Endre, Z., Gobe, G.C., Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 69 (2006), 1806–1813.
8. 8 Chatterjee, P.K., Pleiotropic renal actions of erythropoietin. Lancet 365 (2005), 1890–1892.
9. 9 Song, Y.R., Lee, T., You, S.J., et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol 30 (2009), 253–260.
10. 10 Yoo, Y.C., Shim, J.K., Kim, J.C., Jo, Y.Y., Lee, J.H., Kwak, Y.L., Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 115 (2011), 929–937.
11. 11 de Seigneux, S., Ponte, B., Weiss, L., et al. Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol, 13, 2012, 132.
12. 12 Kim, J.H., Shim, J.K., Song, J.W., Song, Y., Kim, H.B., Kwak, Y.L., Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety. Crit Care, 17, 2013, R254.
13. 13 Cao, Y., Erythropoietin in cancer: a dilemma in risk therapy. Trends Endocrinol Metab 24 (2013), 190–199.
14. 14 Masuda, S., Nagao, M., Takahata, K., et al. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 268 (1993), 11208–11216.
15. 15 Oh, S.W., Chin, H.J., Chae, D.W., Na, K.Y., Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting. J Korean Med Sci 27 (2012), 506–511.
16. 16 McCluskey, S.A., Cheung, W.K., Katznelson, R., et al. The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery. Eur J Clin Pharmacol 65 (2009), 273–279.
17. 17 Moon, C., Krawczyk, M., Paik, D., Lakatta, E.G., Talan, M.I., Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window. Cardiovasc Drugs Ther 19 (2005), 243–250.
18. 18 Solling, C., Christensen, A.T., Nygaard, U., et al. Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia. Acta Anaesthesiol Scand 55 (2011), 411–421.
19. 19 Poulsen, T.D., Andersen, L.W., Steinbruchel, D., Gotze, J.P., Jorgensen, O.S., Olsen, N.V., Two large preoperative doses of erythropoietin do not reduce the systemic inflammatory response to cardiac surgery. J Cardiothorac Vasc Anesth 23 (2009), 316–323.
20. 20 Song, S.W., Yoo, K.J., Shin, Y.R., Lim, S.H., Cho, B.K., Effects of intermittent lower body perfusion on end-organ function during repair of acute DeBakey type I aortic dissection under moderate hypothermic circulatory arrest. Eur J Cardiothorac Surg 44 (2013), 1070–1075.
21. 21 Santhanam, A.V., d'Uscio, L.V., Katusic, Z.S., Cardiovascular effects of erythropoietin an update. Adv Pharmacol 60 (2010), 257–285.
22. 22 Lindenblatt, N., Menger, M.D., Klar, E., Vollmar, B., Darbepoetin-alpha does not promote microvascular thrombus formation in mice: role of eNOS-dependent protection through platelet and endothelial cell deactivation. Arterioscler Thromb Vasc Biol 27 (2007), 1191–1198.
23. 23 Tie, H.T., Luo, M.Z., Lin, D., Zhang, M., Wan, J.Y., Wu, Q.C., Erythropoietin administration for prevention of cardiac surgery-associated acute kidney injury: a meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg 48 (2015), 32–39.
24. 24 Kim, W.H., Lee, S.M., Choi, J.W., et al. Simplified clinical risk score to predict acute kidney injury after aortic surgery. J Cardiothorac Vasc Anesth 27 (2013), 1158–1166.
25. 25 Julier, K., da Silva, R., Garcia, C., et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 98 (2003), 1315–1327.
26. 26 Wong, G.T., Huang, Z., Ji, S., Irwin, M.G., Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. J Cardiothorac Vasc Anesth 24 (2010), 790–796.